|
HBV | Abstract Library |
 |
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
2. | Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis |
|
Surg Res. 2023 Mar;283:1078-1090. doi: 10.1016/j.jss.2022.10.078.Epub 2022 Dec 15.
Colin C Yost 1, Diana C Jimenez 1, Matthew P Weber 1, Elizabeth J Maynes 1, Katherine A Belden 2, Vakhtang Tchantchaleishvili 1, H Todd Massey 1, David A Sass 3, J Eduardo Rame 4, John J Zurlo 2, Nana Aburjania 5
|
|
|
3. | Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities |
|
Am J Transplant. 2023 Apr 26;S1600-6135(23)00428-8. doi: 10.1016/j.ajt.2023.04.024.Online ahead of print.
Anshul Bhatnagar 1, Sameer Prakash 2, Peter Lymberopoulos 3, Cameron Goff 1, Anjiya Shaikh 4, Donghee Kim 5, Aijaz Ahmed 5, Carl Berg 6, Susanna Naggie 7, Fasiha Kanwal 8, George Cholankeril 9, Tzu-Hao Lee 10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11. | Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center |
|
United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376.Epub 2023 Mar 25.
Mathias Jachs 1, Raphael Sauberer 1, Alexander Stiegler 1, Anton Dechêne 1, Raphael Tazreiter 1, Lukas Hartl 1, David Bauer 1, Lorenz Balcar 1, Robert Strassl 2, Mattias Mandorfer 1, Michael Trauner 1, Petra Munda 1, Peter Ferenci 1, Thomas Reiberger 1
|
|
|
12. | A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B |
|
J Hepatol. 2023 May;78(5):926-936.doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28.
Florian van Bömmel 1, Kerstin Stein 2, Renate Heyne 3, Jörg Petersen 4, Peter Buggisch 4, Christoph Berg 5, Stefan Zeuzem 6, Andreas Stallmach 7, Martin Sprinzl 8, Eckart Schott 9, Anita Pathil-Warth 10, Ulrike von Arnim 11, Verena Keitel 12, Jürgen Lohmeyer 13, Karl-Georg Simon 14, Christian Trautwein 15, Andreas Trein 16, Dietrich Hüppe 17, Markus Cornberg 18, Frank Lammert 19, Patrick Ingiliz 20, Reinhart Zachoval 21, Holger Hinrichsen 22, Alexander Zipprich 23, Hartmuth Klinker 24, Julian Schulze Zur Wiesch 25, Anett Schmiedeknecht 26, Oana Brosteanu 26, Thomas Berg 27
|
|
|
|
|
|
|
15. | Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States |
|
Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.
Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
|
|
|
|
|
|
|
|
|
19. | Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial |
|
Sex Transm Infect. 2023 Mar;99(2):140-142.doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8.
Paul Le Turnier 1 2 3, Isabelle Charreau 4, Audrey Gabassi 5 6, Diane Carette 4, Laurent Cotte 7, Gilles Pialoux 8, Cécile Tremblay 9, Bruno Spire 10, Marie-Laure Chaix 5 6, Laurence Meyer 4 11, Catherine Capitant 4, Constance Delaugerre 5 6, François Raffi # 12 2, Jean-Michel Molina # 6 13; ANRS IPERGAY study group
|
|
|
|
|
|
|
|
|
23. | Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination |
|
Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006.Epub 2023 Feb 13.
Giuseppina Brancaccio 1, Barbara Coco 2, Alessandra Nardi 3, Maria Giovanna Quaranta 4, Maria Elena Tosti 4, Luigina Ferrigno 4, Irene Cacciola 5, Vincenzo Messina 6, Luchino Chessa 7, Filomena Morisco 8, Michele Milella 9, Francesco Barbaro 10, Alessia Ciancio 11, Francesco Paolo Russo 12, Nicola Coppola 13, Pierluigi Blanc 14, Ernesto Claar 15, Gabriella Verucchi 16, Massimo Puoti 17, Anna Linda Zignego 18, Liliana Chemello 19, Salvatore Madonia 20, Stefano Fagiuoli 21, Alfredo Marzano 22, Carlo Ferrari 23, Pietro Lampertico 24, Vito Di Marco 25, Antonio Craxì 26, Teresa Antonia Santantonio 27, Giovanni Raimondo 5, Maurizia R Brunetto 2, Giovanni Battista Gaeta 28, Loreta A Kondili 29; PITER collaborating investigators
|
|
|
24. | Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature |
|
Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780.eCollection 2023.
Cesare Mazzaro 1, Riccardo Bomben 1, Marcella Visentini 2, Laura Gragnani 3, Luca Quartuccio 4, Francesco Saccardo 5, Marco Sebastiani 6, Davide Filippini 7, Gianfranco Lauletta 8, Giuseppe Monti 5, Valter Gattei 1
|
|
|
|
|
|
|
|
|
|
|
29. | Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection |
|
Gut. 2023 Jan 25;gutjnl-2022-328041. doi: 10.1136/gutjnl-2022-328041. Online ahead of print.
Harry L A Janssen 1 2, Jinlin Hou 3, Tarik Asselah 4, Henry L Y Chan 5, Fabien Zoulim 6, Yasuhito Tanaka 7, Ewa Janczewska 8, Ronald G Nahass 9, Stefan Bourgeois 10, Maria Buti 11, Pietro Lampertico 12 13, Oliver Lenz 14, Thierry Verbinnen 14, Joris Vandenbossche 14, Willem Talloen 14, Ronald Kalmeijer 15, Maria Beumont 15, Michael Biermer 16, Umesh Shukla 15
|
|
|
|
|
31. | Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B |
|
Dig Dis. 2023;41(1):115-123. doi: 10.1159/000526933. Epub 2022 Sep 7.
Daniel Q Huang 1 2, Dong Hyun Lee 3 4, Michael H Le 4, An Le 4, Yee Hui Yeo 4, Huy N Trinh 5, Mimi Chung 6, Vy Nguyen 4, Tiffani Johnson 7, Jian Q Zhang 8, Clifford Wong 9, Christopher Wong 9, Jiayi Li 10, Ramsey Cheung 4 11, Mindie H Nguyen 4
|
|
|
32. | Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure |
|
Gut. 2023 Jan 27;gutjnl-2022-328380. doi: 10.1136/gutjnl-2022-328380. Online ahead of print.
Lena Allweiss 1 2, Barbara Testoni 3 4, Mei Yu 5, Julie Lucifora 3 4 6, Chunkyu Ko 7 8, Bingqian Qu 9 10, Marc Lütgehetmann 2 11, Haitao Guo 12 13, Stephan Urban 2 9, Simon P Fletcher 5, Ulrike Protzer 2 7, Massimo Levrero 3 4, Fabien Zoulim 14 4, Maura Dandri 15 2
|
|
|
|
|
|
|
|
|
36. | Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes |
|
Diabetologia. 2022 Jul;65(7):1108-1118. doi: 10.1007/s00125-022-05701-w. Epub 2022 Apr 30.
Clemens Kamrath 1, Sascha R Tittel 2 3, Desiree Dunstheimer 4, Elke Fröhlich-Reiterer 5, Markus Freff 6, Claudia Böttcher 7, Nadine Scheffler 8, Stefanie Lenze 9, Elke Gericke 10, Susanne Thiele 11, Reinhard W Holl 2 3
|
|
|
|
|
|
|
|
|
|
|
41. | Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways |
|
J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Benjamin J Mooney 2, Rosemary Millen 2, Rachel Morris 2, Sara Vogrin 2, Vijaya Sundararajan 3, Dilip Ratnam 4, Miriam T Levy 5, John S Lubel 6 7, Amanda J Nicoll 8, Simone I Strasser 9 10, William Sievert 4 11, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, Scott Bowden 17, Stephen A Locarnini 17, Alexander J Thompson 1 2, Kumar Visvanathan 1 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48. | Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection |
|
Antimicrob Agents Chemother. 2022 Dec 15;e0134822. doi: 10.1128/aac.01348-22.Online ahead of print.
Dara Burdette 1, Anastasia Hyrina 1, Zhijuan Song 1, Rudolf K Beran 1, Tara Cheung 1, Sarah Gilmore 1, Tetsuya Kobayashi 1, Li Li 1, Yang Liu 1, Anita Niedziela-Majka 1, Jonathan Medley 1, Upasana Mehra 1, Philip Morganelli 1, Nikolai Novikov 1, Congrong Niu 1, Danny Tam 1, Jennifer Tang 1, Jianhong Wang 1, Qin Yue 1, Simon P Fletcher 1, Meghan M Holdorf 1, William E Delaney 4th 1, Becket Feierbach 1, Scott Lazerwith 1
|
|
|
|
|
|
|
|
|
52. | EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B |
|
Antivir Ther. 2022 Dec;27(6):13596535221127848. doi: 10.1177/13596535221127848.
Jordan J Feld 1, Eric Lawitz 2, Tuan Nguyen 3, Jacob Lalezari 4, Tarek Hassanein 5, Paul Martin 6, Steven-Huy Han 7, Douglas Dieterich 8, Jeanne-Marie Giard 9, Guy De La Rosa 10, Alaa Ahmad 10, Ed Luo 10, Annie L Conery 10, Nathalie Adda 10
|
|
|
|
|
54. | Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B |
|
Aliment Pharmacol Ther. 2022 Nov 25. doi: 10.1111/apt.17299. Online ahead of print.
Josef Wagner 1 2, Lilly Yuen 1 3, Margaret Littlejohn 1, Vitina Sozzi 1, Kathy Jackson 1, Ross Martin 4, Thomas Aeschbacher 4, Vithika Suri 4, Susanna K Tan 4, Becket Feierbach 4, Anuj Gaggar 4, Patrick Marcellin 5, Maria Buti Ferret 6, Harry L A Janssen 7, Ed Gane 8, Niamh Meagher 3, David J Price 3 9, Darren Wong 1 10, Alexander T Thompson 10, Peter A Revill 1 3 11
|
|
|
|
|
56. | Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom |
|
Cost Eff Resour Alloc. 2022 Nov 14;20(1):60. doi: 10.1186/s12962-022-00388-7.
Jack Williams 1 2, Peter Vickerman 3 4, Elizabeth Smout 5, Emma E Page 6, Khine Phyu 6, Mark Aldersley 6, Gaia Nebbia 7, Sam Douthwaite 7, Laura Hunter 8, Murad Ruf 9, Alec Miners 10 11
|
|
|
|
|
|
|
59. | Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection |
|
N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027.Epub 2022 Nov 8.
Man-Fung Yuen 1, Seng-Gee Lim 1, Robert Plesniak 1, Keiji Tsuji 1, Harry L A Janssen 1, Cristina Pojoga 1, Adrian Gadano 1, Corneliu P Popescu 1, Tatyana Stepanova 1, Tarik Asselah 1, Gheorghe Diaconescu 1, Hyung Joon Yim 1, Jeong Heo 1, Ewa Janczewska 1, Alexander Wong 1, Nevin Idriz 1, Michio Imamura 1, Giuliano Rizzardini 1, Koichi Takaguchi 1, Pietro Andreone 1, Manuela Arbune 1, Jinlin Hou 1, Sung Jae Park 1, Andrei Vata 1, Jennifer Cremer 1, Robert Elston 1, Tamara Lukic 1, Geoff Quinn 1, Lauren Maynard 1, Stuart Kendrick 1, Helene Plein 1, Fiona Campbell 1, Melanie Paff 1, Dickens Theodore 1, B-Clear Study Group
|
|
|
|
|
|
|
|
|
63. | Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial |
|
J Gen Intern Med. 2022 Oct;37(13):3242-3250.doi: 10.1007/s11606-021-07232-3. Epub 2022 Jan 6.
Mandana Khalili 1, Nicole J Kim 2, Janice Y Tsoh 3, Judith M E Walsh 4, L Elizabeth Goldman 4, Ginny Gildengorin 4, Ching Wong 4, Mi T Tran 4, Edgar Yu 3, Michael Thanh Sharp 4, Vivian H LeTran 4, Vi-Van Nguyen 4, Tung T Nguyen 4
|
|
|
64. | Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus |
|
Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101773.doi: 10.1016/j.clinre.2021.101773. Epub 2021 Jul 28.
Vincent Leroy 1, Stéphane Chevaliez 2, Marie Decraecker 3, Dominique Roulot 4, Jean Nana 5, Tarik Asselah 6, Xavier Causse 7, David Durantel 8, Vincent Thibaut 9, Nathalie Ganne-Carrié 4, Christophe Bureau 10, Victor de Lédinghen 3, Marc Bourlière 11
|
|
|
|
|
|
|
67. | Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study |
|
Hum Vaccin Immunother. 2022 Oct 21;2136912. doi: 10.1080/21645515.2022.2136912.Online ahead of print.
Matthias Girndt 1, Manfred Plüer 2, Frank Dellanna 3, Ann K Michelsen 4, Joachim Beige 5, Kai Toussaint 6, Hubert J Wehweck 7, Michael Koch 8, Syrus Hafezi Rachti 9, Justus Faust 10, Hans-Peter Bosselmann 11, Oliver Witzke 12, Robert S Janssen 13, HBV-18 Study Investigators 14
|
|
|
|
|
|
|
|
|
|
|
|
|
73. | Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial |
|
Lancet Infect Dis. 2022 Sep 13;S1473-3099(22)00318-8. doi: 10.1016/S1473-3099(22)00318-8.Online ahead of print.
Heiner Wedemeyer 1, Katrin Schöneweis 2, Pavel Bogomolov 3, Antje Blank 4, Natalia Voronkova 5, Tatiana Stepanova 6, Olga Sagalova 7, Vladimir Chulanov 8, Marina Osipenko 9, Viacheslav Morozov 10, Natalia Geyvandova 11, Snezhana Sleptsova 12, Igor G Bakulin 13, Ilsiyar Khaertynova 14, Marina Rusanova 15, Anita Pathil 16, Uta Merle 17, Birgit Bremer 18, Lena Allweiss 19, Florian A Lempp 20, Kerstin Port 18, Mathias Haag 21, Matthias Schwab 22, Julian Schulze Zur Wiesch 19, Markus Cornberg 18, Walter E Haefeli 4, Maura Dandri 19, Alexander Alexandrov 23, Stephan Urban 24
|
|
|
|
|
|
|
|
|
77. | Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark |
|
J Viral Hepat. 2022 Sep;29(9):727-736. doi: 10.1111/jvh.13713. Epub 2022 Jun 9.
Signe Bollerup 1, Sofie Hallager 1, Frederik Engsig 1, Amanda Mocroft 2 3, Henrik Krarup 4 5, Lone G Madsen 6 7, Peter Thielsen 8, Ulla Balslev 9, Helene Mens 10, Toke S Barfod 11, Mette R Clausen 12, Lise Hobolth 13, Alex L Laursen 14, Britta Tarp 15, Birgit T Roege 16, Jesper B Hansen 5, Lone Mygind 17, Peer B Christensen 18 19, Jan Gerstoft 7 20, Nina Weis 1 7
|
|
|
|
|
|
|
|
|
|
|
82. | Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study |
|
Clin Epidemiol. 2022 Jul 18;14:879-888. doi: 10.2147/CLEP.S361910. eCollection 2022.
Frederik Faergemann Lau 1, Signe Bollerup 1, Frederik Engsig 1, Henrik Krarup 2, Lone Hagens Mygind 3, Jesper Bach Hansen 3, Lone Galmstrup Madsen 4 5, Peter Thielsen 6, Ulla Balslev 7, Lars Nørregaard Nielsen 8, Toke S Barfod 9, Mette Rye Clausen 10, Lise Hobolth 11, Alex Lund Laursen 12, Britta Tarp 13, Birgit T Roege 14, Jan Gerstoft 15, Peer Brehm Christensen 16 17, Nina Weis 1 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
91. | Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care |
|
Liver Int. 2022 Sep 1. doi: 10.1111/liv.15414. Online ahead of print.
Rachael Jacob 1 2, David S Prince 1 2, Joseph L Pipicella 1 3, Angela Nguyen 1 4, Melissa Bagatella 1, Frank Alvaro 1 5, Michael Maley 1 3 5, Hong Foo 1 5, Paul Middleton 1 2 6, Tahrima Kayes 1, Julia DiGirolamo 1, Scott A Davison 1 2, Miriam T Levy 1 2 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98. | The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study |
|
HIV Med. 2022 Jul;23(6):585-598. doi: 10.1111/hiv.13210. Epub 2021 Dec 9.
Amanda Mocroft 1 2, Jose M Miro 3, Gilles Wandeler 4, Josep M Llibre 5, Anders Boyd 6 7, Kathrin van Bremen 8, Marek Beniowski 9, Julia Mikhalik 10, Matthias Cavassini 11, Fernando Maltez 12, Claudine Duvivier 13 14 15 16, Caterina Uberti Foppa 17, Brygida Knysz 18, Elzbieta Bakowska 19, Elena Kuzovatova 20, Pere Domingo 21, Alexandra Zagalo 22, Jean-Paul Viard 23, Olaf Degen 24, Ana Milinkovic 25, Thomas Benfield 26, Lars Peters 1, EuroSIDA study group
|
|
|
|
|
100. | Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection |
|
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00653-X.doi: 10.1016/j.cgh.2022.06.015. Online ahead of print.
Jordan J Feld 1, Wendy C King 2, Marc G Ghany 3, Kyong-Mi Chang 4, Norah Terrault 5, Robert P Perrillo 6, Mandana Khalili 7, Amanda S Hinerman 2, Harry LA Janssen 8, Anna S Lok 9, Hepatitis B Research Network (HBRN)
|
|
|
|
|
|
|
|
|
|
|
105. | Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance |
|
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00660-7.doi: 10.1016/j.cgh.2022.06.019. Online ahead of print.
Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6, HBRN HBV Novel Assays Group (Corporate authorship); Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
|
|
|
|
|
107. | Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScore |
|
Liver Int. 2022 Jul 21. doi: 10.1111/liv.15372. Online ahead of print.
Cynthuja Thilakanathan 1 2, Tahrima Kayes 1, Julia Di Girolamo 1, Vi Nguyen 2, Anne Glass 1, Sicha Manandhar 1, Joseph Lawler 3, Chris Meredith 3, Michael Maley 2 4, Andrew Lloyd 5, Miriam T Levy 1 2
|
|
|
|
|
|
|
110. | Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion |
|
J Hepatol. 2022 Jul 15;S0168-8278(22)02935-X. doi: 10.1016/j.jhep.2022.07.003.Online ahead of print.
George V Papatheodoridis 1, Vasileios Lekakis 1, Thodoris Voulgaris 2, Pietro Lampertico 3, Thomas Berg 4, Henry L Y Chan 5, Jia-Horng Kao 6, Norah Terrault 7, Anna S Lok 8, K Rajender Reddy 9
|
|
|
111. | Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease |
|
Pediatr Qual Saf. 2022 Jun 23;7(4):e570. doi: 10.1097/pq9.0000000000000570.eCollection 2022 Jul-Aug.
Megan Megan McNicol 1, Amy Donegan 2, Kate Hawa 3, Angelique E Boutzoukas 3, Barb Drobnic 2, Melanie Oates 2, Maudie Orraca-Tetteh 2, Hilary K Michel 2, Ross M Maltz 2, Jennifer L Dotson 2, Don Buckingham 4, Brendan Boyle 2, Monica I Ardura 5
|
|
|
112. | Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection |
|
J Hepatol. 2022 Jun 10;S0168-8278(22)00348-8. doi: 10.1016/j.jhep.2022.05.027.Online ahead of print.
Mark S Sulkowski 1, Kosh Agarwal 2, Xiaoli Ma 3, Tuan T Nguyen 4, Eugene R Schiff 5, Hie-Won L Hann 6, Douglas T Dieterich 7, Ronald G Nahass 8, James S Park 9, Sing Chan 10, Steven-Huy B Han 11, Edward J Gane 12, Michael Bennett 13, Katia Alves 14, Marc Evanchik 14, Ran Yan 14, Qi Huang 14, Uri Lopatin 14, Richard Colonno 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Ira M Jacobson 9, Walid S Ayoub 16, Frank Weilert 17, Natarajan Ravendhran 18, Alnoor Ramji 19, Paul Yien Kwo 20, Magdy Elkhashab 21, Tarek Hassanein 22, Ho S Bae 23, Jacob P Lalezari 15, Scott K Fung 24, Man-Fung Yuen 25
|
|
|
|
|
114. | Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection |
|
Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22.
Tahrima Kayes 1 2, Harry Crane 1 2, Allison Symonds 3, Julie Dumond 3, Mackenzie Cottrell 3, Julia Di Girolamo 1 2, Sicha Manandhar 1 2, Tien Huey Lim 4, Edward Gane 5, Angela Kashuba 3, Miriam T Levy 1 2 6
|
|
|
115. | Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022 |
|
MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2.
Rebecca J Free, Marilyn E Levi, James S Bowman, Danae Bixler, John T Brooks, Kate Buchacz, Anne Moorman, James Berger, Sridhar V Basavaraju
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
129. | Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis |
|
JAMA Netw Open. 2022 Jun 1;5(6):e2219407.doi: 10.1001/jamanetworkopen.2022.19407.
Darren Jun Hao Tan 1, Cheng Han Ng 1, Phoebe Wen Lin Tay 1, Nicholas Syn 1, Mark D Muthiah 1 2 3, Wen Hui Lim 1, Ansel Shao Pin Tang 1, Kai En Lim 1, Grace En Hui Lim 4, Nobuharu Tamaki 5, Beom Kyung Kim 5 6 7, Margaret Li Peng Teng 1 2 3, James Fung 8, Rohit Loomba 9, Mindie H Nguyen 10, Daniel Q Huang 1 2 3 9
|
|
|
|
|
|
|
|
|
133. | Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels |
|
Aliment Pharmacol Ther. 2022 May 6. doi: 10.1111/apt.16968. Online ahead of print.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Despina Anagnostou 1, Sara Vogrin 2, Vijaya Sundararajan 2 3, Dilip Ratnam 4 5, Miriam T Levy 6, John S Lubel 7 8, Amanda J Nicoll 9, Simone I Strasser 10 11, William Sievert 4 5, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, D Scott Bowden 17, Stephen A Locarnini 17, Kumar Visvanathan 1 2, Alexander J Thompson 1 2
|
|
|
|
|
|
|
|
|
137. | Australian consensus recommendations for the management of hepatitis B |
|
Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.
John S Lubel 1 2, Simone I Strasser 3 4, Alexander J Thompson 5 6, Benjamin C Cowie 7 8, Jennifer MacLachlan 7, Nicole L Allard 6 7, Jacinta Holmes 5 6, William W Kemp 1, Avik Majumdar 3, David Iser 5, Jess Howell 2 6 9, Gail V Matthews 10 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149. | Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data |
|
Aliment Pharmacol Ther. 2022 Apr;55(8):921-943. doi: 10.1111/apt.16788.Epub 2022 Feb 17.
Young-Suk Lim 1, Wai-Kay Seto 2 3, Masayuki Kurosaki 4, Scott Fung 5, Jia-Horng Kao 6, Jinlin Hou 7, Stuart C Gordon 8, John F Flaherty 9, Leland J Yee 9, Yang Zhao 9, Kosh Agarwal 10, Pietro Lampertico 11 12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
158. | Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy |
|
Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5.Epub 2022 Feb 3.
Manoj Kumar 1, Zaigham Abbas 2, Milad Azami 3, Maria Belopolskaya 4, A K Dokmeci 5, Hasmik Ghazinyan 6, Jidong Jia 7, Ankur Jindal 8, Han Chu Lee 9, Wei Lei 10, Seng Gee Lim 11, Chun-Jen Liu 12, Qiang Li 13, Mamun Al Mahtab 14, David H Muljono 15, Madunil Anuk Niriella 16, Masao Omata 17 18, Diana A Payawal 19, Shiv K Sarin 20, Olivier Ségéral 21, Tawesak Tanwandee 22, Nirupma Trehanpati 23, Kumar Visvanathan 24, Jin Mo Yang 25, Man-Fung Yuen 26, Yingjie Zheng 27, Y H Zhou 28
|
|
|
|
|
|
|
161. | The viral hepatitis B care cascade: A population-based comparison of immigrant groups |
|
Hepatology. 2022 Mar;75(3):673-689. doi: 10.1002/hep.32162. Epub 2021 Dec 7.
Abdool S Yasseen 1 2 3, Jeffrey C Kwong 1 2 3 4 5, Jordan J Feld 1 2 4 6, Rafal Kustra 1, Liane MacDonald 1 3, Christina C Greenaway 7 8 9, Naveed Z Janjua 10, Tony Mazzulli 3 4, Morris Sherman 4, Lauren Lapointe-Shaw 2 4 6, Beate Sander 1 2 3 4, Natasha S Crowcroft 1 2 3
|
|
|
|
|
|
|
|
|
|
|
|
|
167. | Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection |
|
J Antimicrob Chemother. 2022 Mar 31;77(4):1102-1110.doi: 10.1093/jac/dkab491.
Ed J Gane 1, Christian Schwabe 2, Elina Berliba 3 4, Pisit Tangkijvanich 5, Alina Jucov 3 4, Nelea Ghicavii 3, Thierry Verbinnen 6, Oliver Lenz 6, Willem Talloen 6, Thomas N Kakuda 7, Chris Westland 7, Megha Patel 7, Jeysen Z Yogaratnam 7, Leonard Dragone 7, Pieter Van Remoortere 8
|
|
|
|
|
|
|
170. | Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study |
|
J Viral Hepat. 2021 Dec;28(12):1690-1698. doi: 10.1111/jvh.13608.Epub 2021 Sep 29.
Robin Erken 1, Patrice Andre 2, Elise Roy 3, Neeltje Kootstra 4, Noelie Barzic 3, Hugo Girma 3, Christian Laveille 5, Pauline Radreau-Pierini 3, Raphael Darteil 3, Jacky Vonderscher 3, Pietro Scalfaro 3, Pisit Tangkijvanich 6, Robert Flisiak 7, Henk Reesink 8
|
|
|
|
|
172. | Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner |
|
Vaccine. 2022 Feb 23;40(9):1334-1341.doi: 10.1016/j.vaccine.2022.01.005. Epub 2022 Jan 31.
Laure F Pittet 1, Lianne Cox 2, Bridget Freyne 3, Susie Germano 4, Rhian Bonnici 5, Kaya Gardiner 6, Susan Donath 7, Clare L Collins 8, Dan Casalaz 9, Roy Robins-Browne 10, Katie L Flanagan 11, Nicole L Messina 12, Nigel Curtis 13
|
|
|
|
|
|
|
|
|
176. | Incidence of malignancies among patients with chronic hepatitis B in US health care organizations, 2006-2018 |
|
J Infect Dis. 2022 Jan 17;jiac011. doi: 10.1093/infdis/jiac011. Online ahead of print.
Philip R Spradling 1, Jian Xing 1, Y Zhong 1, Loralee B Rupp 2, Anne C Moorman 1, Mei Lu 2, Eyasu H Teshale 1, Mark A Schmidt 3, Yihe G Daida 4, Joseph A Boscarino 5, Stuart C Gordon 2 6, Chronic Hepatitis Cohort Study (CHeCS) Investigators
|
|
|
177. | Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection |
|
J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.
Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
|
|
|
178. | Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose |
|
Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.
Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
|
|
|
|
|
180. | Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection |
|
J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.
Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
|
|
|
181. | Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose |
|
Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.
Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
|
|
|
|
|
183. | Serological testing on the ADVIA Centaur system for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in specimens from deceased and living individuals demonstrates equivalent results l |
|
Transpl Infect Dis. 2022 Feb 17;e13802. doi: 10.1111/tid.13802. Online ahead of print.
Theodore B Wright 1, Sai Patibandla 1, Renee Walsh 1, Rachel Fonstad 1, Matthew Gee 1, Vera Bitcon 1, Julie Hopper 2, Susie J Braniff 3, Susan Best 3, Scott Read 4
|
|
|
184. | Assessing the cost-utility of universal hepatitis B vaccination among adults |
|
J Infect Dis. 2022 Mar 9;jiac088. doi: 10.1093/infdis/jiac088. Online ahead of print.
Eric W Hall 1 2, Mark K Weng 3, Aaron M Harris 3, Sarah Schillie 4, Noele P Nelson 3, Ismael R Ortega-Sanchez 4, Elizabeth Rosenthal 5, Patrick S Sullivan 2, Ben Lopman 2, Jeb Jones 2, Heather Bradley 6, Eli S Rosenberg 5 7
|
|
|
185. | Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis |
|
Hepatology. 2022 Jan 31. doi: 10.1002/hep.32380. Online ahead of print.
Heejoon Jang 1 2, Yun Bin Lee 1, Hyemi Moon 3, Jong-Won Chung 4, Joon Yeul Nam 1, Eun Ju Cho 1, Jeong-Hoon Lee 1, Su Jong Yu 1, Yoon Jun Kim 1, Juneyoung Lee 3, Jung-Hwan Yoon 1
|
|
|
186. | Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks |
|
AIDS. 2022 Feb 14. doi: 10.1097/QAD.0000000000003193. Online ahead of print.
Claudia Hawkins 1, Minhee Kang, Debika Bhattacharya, Gavin Cloherty, Mary Kuhns, Roy Matining, Chloe Thio, Wadzanai Samaneka, Lameck Chinula, Nyirenda Mulinda, Sharlaa Badal-Faesen, Patcharaphan Sugandhavesa, Javier Lama, Simani Gaseitsiwe, Vera Holzmayer, Mark Anderson, Robert Murphy, Marion Peters
|
|
|
|
|
188. | Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults |
|
Dig Dis Sci. 2022 Feb;67(2):676-688. doi: 10.1007/s10620-021-06860-3. Epub 2021 Feb 8.
Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, David E Kleiner 4, Amanda S Hinerman 2, Mark Sulkowski 5, Raymond T Chung 6, Mamta K Jain 7, M Auricio Lisker-Melman 8, David K Wong 9, Marc G Ghany 4, HBV-HIV Cohort Study of the Hepatitis B Research Network
|
|
|
189. | Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada |
|
J Pediatr. 2021 Oct;237:24-33.e12. doi: 10.1016/j.jpeds.2021.05.035.Epub 2021 May 20.
Simon C Ling 1, Hsing-Hua S Lin 2, Karen F Murray 3, Philip Rosenthal 4, Douglas Mogul 5, Norberto Rodriguez-Baez 6, Sarah Jane Schwarzenberg 7, Jeffrey Teckman 8, Kathleen B Schwarz 5, Hepatitis B Research Network (HBRN)
Hepatitis B Research Network (HBRN):
Hongxia Li, Robert Anders, Hejab Imteyaz, Peter Lee, Kiyoko Oshima, Kim Kafka, Naureen Islam, Shannon M Riggs, Rosemary A Nagy, Jacki Cerkoski, Athena Hau, Daniel Cui, Laurie A Rodgers-Augustyniak, Shirley Montanye, Natasha Feier, Joel Feier, Camille Langlois, Kara L Cooper, Jay H Hoofnagle, Averell H Sherker, Edward Doo, Rebecca J Torrance, Sherry R Hall, Frani Averbach, Tamara Haller, Regina Hardison, Stephanie Kelley, Christina M Lalama, Sharon Lawlor, Manuel Lombardero, Andrew Pelesko, Donna Stoliker, Melissa Weiner, Ella Zadorozny, Qian Zhao
|
|
|
190. | Changes in serum hepatitis B surface and e antigen, IP-10, and aminotransferase levels during combination therapy of immune tolerant chronic hepatitis B |
|
Hepatology. 2022 Feb 21. doi: 10.1002/hep.32400. Online ahead of print.
Robert P Perrillo 1, Hsing-Hua S Lin 2, Kathleen B Schwarz 3, Philip Rosenthal 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Ludmila Prokunina-Olsson 7, Gavin Coherty 8, Jordan Feld 9, Hepatitis B Research Network (HBRN)
|
|
|
|
|
192. | Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014 |
|
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31.Epub 2021 Mar 1.
Stacy R Tressler 1, Maria C Del Rosario 1, Michelle D Kirby 2, Ashley N Simmons 1, Melissa A Scott 1, Sherif Ibrahim 1, Joseph C Forbi 3, Hong Thai 3, Guo-Liang Xia 3, Meghan Lyman 4, Melissa G Collier 3, Priti R Patel 4, Danae Bixler 1
|
|
|
|
|
194. | Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels |
|
J Hepatol. 2022 Jan 26;S0168-8278(22)00020-4. doi: 10.1016/j.jhep.2022.01.007.Online ahead of print.
M J Sonneveld 1, S-M Chiu 2, J Y Park 3, S M Brakenhoff 4, A Kaewdech 5, W K Seto 6, Y Tanaka 7, I Carey 8, M Papatheodoridi 9, F van Bömmel 10, T Berg 11, F Zoulim 12, S H Ahn 13, G N Dalekos 14, N S Erler 15, C Höner Zu Siederdissen 16, H Wedemeyer 17, M Cornberg 18, M F Yuen 19, K Agarwal 20, A Boonstra 21, M Buti 22, T Piratvisuth 23, G Papatheodoridis 24, C-H Chen 25, B Maasoumy 26, CREATE study group
|
|
|
|
|
|
|
197. | An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States |
|
Hepatology. 2021 Aug;74(2):607-626. doi: 10.1002/hep.31782.Epub 2021 May 26.
Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
|
|
|
|
|
|
|
200. | Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be done |
|
Dig Liver Dis. 2021 Oct;53(10):1315-1319. doi: 10.1016/j.dld.2020.10.011. Epub 2020 Nov 6.
Tommaso Stroffolini 1, Anna Lombardi 2, Alessia Ciancio 3, Rosanna Fontana 4, Guido Colloredo 5, Massimo Marignani 6, Maria Vinci 7, Filomena Morisco 8, Sergio Babudieri 9, Luigina Ferrigno 10, Evangelista Sagnelli 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207. | Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial |
|
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.
Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
|
|
|
|
|
|
|
210. | Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial |
|
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.
Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
218. | Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy |
|
Hepatology. 2021 Jun;73(6):2124-2140. doi: 10.1002/hep.31554. Epub 2021 May 21.
Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
226. | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals |
|
Aliment Pharmacol Ther. 2021 Jul 19. doi: 10.1111/apt.16524. Online ahead of print.
Jill Koshiol 1, Ilona Argirion 1, Zhiwei Liu 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly Yu 1, Katherine A McGlynn 1, Jessica L Petrick 1 3, Ligia Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Ruth M Pfeiffer 1, Mei-Hsuan Lee 7, Hwai-I Yang 5
|
|
|
227. | The Inflammatory Cytokine Profile Associated with Liver Damage is Broader and Stronger in Chronic Hepatitis B Patients Compared to Acute Hepatitis B Patients |
|
J Infect Dis. 2021 Jul 21;jiab373. doi: 10.1093/infdis/jiab373. Online ahead of print.
Alexandra Johnson Valiente 1 2, Kin Seng Liem 2 3, Kathleen B Schwarz 4 5, Philip Rosenthal 6, Karen F Murray 7, Douglas Mogul 5, Jeffery Teckman 8, Norberto Rodriguez-Baez 9, Sarah Jane Schwarzenberg 10, Jordan J Feld 2 11, David K Wong 2, Lia L Lewis-Ximenez 12, Georg Lauer 13, Bettina E Hansen 2 14, Simon C Ling 15 16, Harry L A Janssen 2 11, Adam J Gehring 1 2 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
236. | Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019 |
|
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.
Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
|
|
|
|
|
238. | Family imaginaries in the disclosure of a blood-borne virus |
|
Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.
Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
|
|
|
239. | Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study |
|
BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.
Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
|
|
|
|
|
241. | Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America |
|
Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.
Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
|
|
|
|
|
|
|
|
|
|
|
|
|
247. | Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study |
|
BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.
Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
|
|
|
248. | An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States |
|
Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.
Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
|
|
|
|
|
|
|
|
|
|
|
253. | Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C |
|
J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.
Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
261. | Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity |
|
Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.
Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
|
|
|
|
|
| | | | | |